Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-043707

Director sold 550 shares at an average $55.15 ($30,333)

From the SEC's structured data for this filing

Trades in this filing

McLoughlin Margaret · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-28 Sale : show line 1 in the form −200 $55.01 $11,002 350 D
2021-06-28 Sale : show line 2 in the form −250 $55.03 $13,758 100 D
2021-06-28 Sale : show line 3 in the form −100 $55.73 $5,573 0 D
Open-market sales · 550 sh · avg $55.15 · $30,333
Loading xslF345X03/doc4.xml…